TGF-fi tumor suppressor function. However, to date the role of the TGF-/3 pathway at specific stages ingastrointestinal (Gl) tumor development such as metaplasia, dysplasia and carcinoma remains poorlydelineated, particularly in conjunction with activation of oncogenic pathways. We previously found thatdeletion of ELF results in a dramatic and spontaneous formation of liver and gastrointestinal (Gl) cancers,with a splice site mutation in elf exon 15 in 11% of human Gl cancer cell lines tested so far.A surprising and serendipitous recent discovery by us is that elf' and elf^/SmadS^' mice developvisceromegaly and multiple Gl cancers (70% of mice), including metastatic pancreatic, hepatocellular,intestinal adenocarcinomas and others spontaneously, providing compelling evidence as a mouse model ofBeckwith-Wiedemann syndrome (BWS), a hereditary human cancer syndrome. In addition, 90% of elf'''/Smad4*/~ mice develop gastric cancer, 20% develop colonic adenomas, and ELF expression is lost inhuman gastric cancer as well as Dukes B1 adenomas indicating a role for ELF in suppression of earlyhuman gastrointestinal cancer. Molecular profiling of the tumors in these mice and human Gl cancersdemonstrate markedly high levels of cell cycle regulators that include CDK4, cyclin D1 and PRAJA anELF/Smad3 specific E3 ligase. Interestingly, SmadS has recently been shown to be a CDK4 substrate, yetSmad3 mutant mice do not develop cancers. Thus, activated CDK4 and PRAJA associate with ELF with orwithout Smad3 and most likely exert their oncogenic activity through suppression ofELF/SmadS.
Our AIMS are to:1. Determine a functional interaction between ELF, SmadS, and CDK4, and the effect of loss elf, SmadS orSmad4 on CDK4 enzyme activity, towards testing CDK4 inhibitors from project 4, Vitamin D analogs fromproject 2, as well as developing new therapaeutics targeted allosterically at CDK4 -ELF-Smad3 interaction.2. Investigate the molecular basis for the differential effects of PRAJA on ELF and SmadS towardsgenerating new inhibitors targeted at PRAJA.3. Test whether ELF is mutated in BWS, and potentially whether loss of ELF in combination with PRAJA,CDK4, Smad3, Smad4,TBRII, TERT and c-Myc (the latter two from project 3) represent new specificmolecular markers for early tumor detection/ treatment response of hepatocellular, gastric and pancreaticcancers.Results from this study promise to yield important new therapeutics and will be a first step toward the goal ofindividualized cancer treatment based on the functional molecular characteristics of these lethal tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA130821-01A1
Application #
7534173
Study Section
Special Emphasis Panel (ZCA1-RPRB-O (M1))
Project Start
2008-05-01
Project End
2013-08-31
Budget Start
2008-09-10
Budget End
2009-08-31
Support Year
1
Fiscal Year
2008
Total Cost
$157,300
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Korkut, Anil; Zaidi, Sobia; Kanchi, Rupa S et al. (2018) A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-? Superfamily. Cell Syst 7:422-437.e7
Chen, Jian; Zaidi, Sobia; Rao, Shuyun et al. (2018) Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-? Pathway. Gastroenterology 154:195-210
Lin, Shu-Hong; Raju, Gottumukkala S; Huff, Chad et al. (2018) The somatic mutation landscape of premalignant colorectal adenoma. Gut 67:1299-1305
Rao, Shuyun; Zaidi, Sobia; Banerjee, Jaideep et al. (2017) Transforming growth factor-? in liver cancer stem cells and regeneration. Hepatol Commun 1:477-493
Zhou, Xin; Patel, Darshan; Sen, Sabyasachi et al. (2017) Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis. J Vasc Surg 65:1161-1169
Gu, Shoujun; Nguyen, Bao-Ngoc; Rao, Shuyun et al. (2017) Alcohol, stem cells and cancer. Genes Cancer 8:695-700
Chen, Jian; Shukla, Vivek; Farci, Patrizia et al. (2017) Loss of the transforming growth factor-? effector ?2-Spectrin promotes genomic instability. Hepatology 65:678-693
Shin, Joshua; Mishra, Viveka; Glasgow, Eric et al. (2017) PRAJA is overexpressed in glioblastoma and contributes to neural precursor development. Genes Cancer 8:640-649
Long, Yin; Sanchez-Espiridion, Beatriz; Lin, Moubin et al. (2017) Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer 123:4066-4074
Mitra, Abhisek; Yan, Jun; Xia, Xueqing et al. (2017) IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient ?2-spectrin+/- mice. Hepatology 65:1222-1236

Showing the most recent 10 out of 139 publications